Ekso Bionics Holdings Inc
$ 4.07
-7.92%
04 Dec - close price
- Market Cap 10,676,600 USD
- Current Price $ 4.07
- High / Low $ 4.46 / 3.50
- Stock P/E N/A
- Book Value 3.69
- EPS -5.38
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.27 %
- ROE -0.85 %
- 52 Week High 14.97
- 52 Week Low 2.73
About
Ekso Bionics Holdings, Inc. is a pioneering leader in the design and development of advanced exoskeleton technology aimed at enhancing mobility and rehabilitation for individuals with physical impairments. Based in Richmond, California, Ekso Bionics offers a range of innovative exoskeleton products and rental options, serving a diverse clientele that includes healthcare providers and industrial sectors. The company’s focus on improving patient outcomes and maximizing human performance positions it favorably within the emerging wearable robotics market, representing a compelling investment opportunity for institutional investors seeking to capitalize on advancements in healthcare technology.
Analyst Target Price
$7.75
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-29 | 2025-07-28 | 2025-04-28 | 2025-03-03 | 2024-10-28 | 2024-07-29 | 2024-04-29 | 2024-03-04 | 2023-10-26 | 2023-07-27 | 2023-04-27 | 2023-03-28 |
| Reported EPS | -0.54 | -1.24 | -0.12 | -0.14 | -0.1 | -0.13 | -0.2 | -0.22 | -0.24 | -0.31 | -0.33 | -0.24 |
| Estimated EPS | -0.965 | -0.08 | -0.16 | -0.08 | -0.1 | -0.13 | -0.16 | -0.11 | -0.31 | -0.28 | -0.31 | -0.22 |
| Surprise | 0.425 | -1.16 | 0.04 | -0.06 | 0 | 0 | -0.04 | -0.11 | 0.07 | -0.03 | -0.02 | -0.02 |
| Surprise Percentage | 44.0415% | -1450% | 25% | -75% | 0% | 0% | -25% | -100% | 22.5806% | -10.7143% | -6.4516% | -9.0909% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: EKSO
2025-11-01 01:03:00
Ekso Bionics Holdings Inc. is exploring major strategic changes, including potentially acquiring a business in a different industry or selling its current exoskeleton operations, despite reporting improved financial results for the third quarter. The company saw a 2% increase in revenue and a reduction in net loss, driven by higher medical division sales and lower manufacturing costs. Following a stock offering that raised $3.7 million, the company's share price surged, although it remains down significantly year-to-date.
2025-10-14 13:36:39
The global construction exoskeleton market is projected to grow from USD 1.06 billion in 2025 to USD 2.78 billion by 2032, driven by investments in wearable technology, regulatory focus on worker safety, and digital integration. The market faces shifts in procurement strategies due to upcoming US tariffs, emphasizing diversification and domestic manufacturing. Key trends include ergonomic support, enhanced safety, and solutions for workforce retention amidst increased adoption across global regions.
2025-06-22 17:13:00
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has seen its share price plummet 31% in the last month, contributing to an 82% decline over the past year. Despite this, its price-to-sales (P/S) ratio of 0.3x is significantly lower than the Medical Equipment industry average, suggesting a potential buying opportunity if the market is overly pessimistic about its future growth. While the company's revenue fell 2.1% last year, analysts project a 21% annual climb in revenue over the next three years, outpacing the industry's 10% forecast.
2025-05-19 16:40:00
Ekso Bionics Holdings, Inc. announced a 1-for-15 reverse stock split effective May 27, 2025, to increase its share price and comply with Nasdaq listing requirements. The split, approved by shareholders, will reduce outstanding shares from approximately 35 million to 2.35 million, with fractional shares rounded up. This aims to boost investor confidence and improve financial metrics, despite indicating prior stock price struggles.
2025-05-15 07:45:00
Ekso Bionics has been accepted into the NVIDIA Connect program, initiating a strategic move to develop the world's first foundation model for human motion in physical rehabilitation. Leveraging NVIDIA's resources, including specialized training and GPU platforms, Ekso Bionics aims to integrate new AI capabilities across its device portfolio. CEO Scott Davis highlights this collaboration as the beginning of their AI journey to enhance exoskeleton technology and improve patient outcomes through personalized rehabilitation.
2025-02-10 12:13:00
Ekso Bionics Holdings, Inc. announced an exclusive partnership with National Seating & Mobility (NSM) for the distribution of its Ekso Indego Personal exoskeleton device within the U.S. complex rehabilitation technology sector. This wearable device helps individuals with spinal cord injuries stand and walk independently, and is noted for its modular design and light weight. The collaboration aims to improve access to this innovative mobility solution, leveraging NSM's expertise and infrastructure.
